Showing results (141-150 of 194) with videos related to
Sort By:
Pageof 20
The Journal of Clinical Investigation|March 1, 1988
Amphipathic segment of the nicotinic receptor alpha subunit contains epitopes recognized by T lymphocytes in myasthenia gravisR Hohlfeld, K V Toyka, L L Miner, et al.Muscle & Nerve|May 1, 1986
Effector mechanisms in myasthenia gravis: end-plate function after passive transfer of IgG, Fab, and F(ab')2 hybrid moleculesR Sterz, R Hohlfeld, K Rajki, et al.Brain : a Journal of Neurology|February 1, 1994
Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosisF Weber, E Meinl, F Aloisi, et al.Der Nervenarzt|August 14, 2015
[Current aspects of therapy conversion for multiple sclerosis]P Kolber, F Luessi, S G Meuth, et al.Journal of Neurology|November 16, 2016
Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degenerationJoachim Havla, T Kümpfel, R Schinner, et al.Der Nervenarzt|January 18, 2011
[Progressive multifocal leukoencephalopathy under natalizumab. Initial possibilities for risk stratification?]C Warnke, O Adams, R Gold, et al.European Journal of Immunology|November 11, 1999
Myasthenia gravis: selective enrichment of antiacetylcholine receptor antibody production in untransformed human B cell culturesF Padberg, M Matsuda, R Fenk, et al.Journal of Neuroimmunology|May 1, 1996
Multiple sclerosis: prospective analysis of TNF-alpha and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activityS Spuler, T Yousry, A Scheller, et al.Der Nervenarzt|September 14, 1999
[Interferon beta-1b for treatment of secondary chronic progressive multiple sclerosis]C Zimmermann, E U Walther, N Goebels, et al.Brain : a Journal of Neurology|December 1, 1994
Multiple sclerosis. Immunomodulatory effects of human astrocytes on T cellsE Meinl, F Aloisi, B Ertl, et al.Pageof 20